An observational study in Ulcerative Colitis and Crohn's Disease, sponsored by Rennes University Hospital. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-02-15.
Sponsored by Rennes University Hospital · Observational
The purpose of the study is to develop a validated French version of the IBDQ in a cohort of patients suffering from Inflammatory bowel diseases, namely Crohn's disease and Ulcerative Colitis.
Importance of measuring subjective aspects of the patient's health, often referred to as quality of life (QoL), become increasingly recognized and integrated into healthcare. For this purpose, The Inflammatory Bowel Disease Questionnaire (IBDQ) is a widely used questionnaire for QoL assessment specific for patients who suffer from inflammatory bowel diseases. However, the IBDQ was originally developed in a cohort of Canadian patients in English language. Since QoL is impacted by underlying cultural trends, any translation of the IBDQ should be reassessed in relation to its validity, reliability, and sensitivity to detect change in the new language and cultural context. While the linguistic French translation of the original IBDQ has been validated, the French IBDQ has never been tested adequately on a French cohort of patient that we aim to perform.
1,073 studies on the registry are indexed under Colitis; 131 are open to participants now.
This study's enrollment of 100 is close to the median of 105 across 247 observational studies indexed under Colitis.
Browse Colitis studies →Rennes University Hospital is the lead sponsor of 440 studies on the registry; 51 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient with definite diagnosis of UC or CD for at least 6 months
Exclusion Criteria:
Other: Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ)
Internal validity, scale F-IBDQ
Chronbach's alpha coefficient, measured at the first visit and at the second visit.
Time frame: Day1 and Month4
External validity, questionnaire SF36
Correlation with the French validated SF-36 and disease activity indexes (Harvey Bradshaw index for Crohn's disease and Simple Colitis Activity Index for ulcerative colitis, measured at the first visit and at the second visit.
Time frame: Day1 and Month4
Discriminant ability, disease activity indexes
Correlation with disease activity indexes, measured at the first visit and at the second visit.
Time frame: Day1 and Month4
Reliability, disease outcomes
Correlation with disease outcomes, measured at the first visit and at the second visit.
Time frame: Day1 and Month4
This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rennes University Hospital